MedPath

Effects of 100% Orange Juice on Skin Health in Women

Not Applicable
Recruiting
Conditions
Skin Health
Interventions
Other: Orange juice
Other: Placebo juice (Fanta)
Registration Number
NCT04861623
Lead Sponsor
University of Florida
Brief Summary

Daily consumption of Orange Juice (OJ) protects skin against UV-induced damages and wrinkling, improves skin barrier function and overall skin health by decreasing oxidative stress, inflammation, and protein glycation. The positive effects of OJ on skin appearance are associated with improvements of the stratum corneum lipidomic and skin microbiome.

Detailed Description

There is a lack of clinical evidence on how 100% orange juice (OJ) affects skin health. Women make over 90% of the decisions on food purchases for family. Skin health is a major concern for women because skin ageing becomes visibly noticeable after age 30 due to UV exposure, oxidative stress, and collagen glycation. The investigators hypothesize that micronutrients in OJ, including vitamin C, flavanones, and carotenoids, protect skin against photoaging and wrinkling by alleviating oxidative stress, inflammation, and collagen glycation. The investigators further propose that daily OJ consumption (16 oz) will improve skin elasticity, barrier function, overall skin appearance and health. The study hypotheses will be tested in a 12-week clinical trial in 24 women aged 45-65 using a randomized, double-blinded, placebo-controlled, crossover design. Placebo will be formulated using SunnyD orange-flavered beverage to match the color, taste, and calorie content of OJ. This research will measure UV-induced skin erythema, wrinkles, smoothness, roughness, elasticity, hydration, pH, melanin, and transepidermal water loss (a skin barrier index) of skin on both face and forearm. Skin strips and swabs will be collected and preserved for future assessments of skin lipids and colonized microorganisms (skin microbiome) because they are key factors affecting skin health. Positive results from this pilot trial will provide clinical evidence on the effectiveness of OJ to maintain skin health and reduce ageing. This research will be carried out by a research team with the experience and facilities for skin research.

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
20
Inclusion Criteria
  • BMI (18.5-29.9)
  • Body weight ≥110 pounds
  • Fitzpatrick skin type 2 and 3.
Exclusion Criteria
  • pregnancy
  • breast-feeding
  • impaired fasting glucose
  • frequent alcohol use
  • history of skin cancer
  • sunbathing and the use of tanning bed, intake of vitamin/mineral supplements
  • habitual high intake of fruits (≥ 2 cups daily)
  • intake of medication that might influence the outcome of the study

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Orange Juice then Placebo juice (Fanta)Orange juiceParticipants will be provided orange juice for 84 days in this arm. After 28 days wash-out period, participants will receive Fanta for 84 days.
Orange Juice then Placebo juice (Fanta)Placebo juice (Fanta)Participants will be provided orange juice for 84 days in this arm. After 28 days wash-out period, participants will receive Fanta for 84 days.
Placebo (Fanta) then Orange juicePlacebo juice (Fanta)Participants will be provided Fanta for 84 days in this arm. After 28 days wash-out period, participants will receive Orange juice for 84 days.
Placebo (Fanta) then Orange juiceOrange juiceParticipants will be provided Fanta for 84 days in this arm. After 28 days wash-out period, participants will receive Orange juice for 84 days.
Primary Outcome Measures
NameTimeMethod
Change from baseline Skin color change after UV irradiation at 84 daysBaseline, 84 days

Irradiation will be applied to dorsal skin (back, scapular region not typically exposed to the sun) with 2 times of minimal erythema dose using an FDA approved UVB phototherapy light and a UV light meter. At baseline, after 42 and 84 days, skin color will be measured before and 24 hours after irradiation. Skin color will be evaluated by a colorimeter using the 3-dimensional color system with L\*, a\*, and b\*-values. L\* and b\* values assess lightness and browning effects, respectively. The a\*-value (red/green-axis) is a measure for reddening (erythema).

Change from baseline skin transepidermal water lossBaseline, 84 days

Skin transepidermal water loss will be measured using a Tewameter to evaluate the water barrier function of the skin. The Tewameter measures the density gradient of the water evaporation from the skin (g/h/m\^2).

Change from baseline skin erythema and melanin indexBaseline, 84 days

Skin erythema and melanin index will be assessed with Mexameter. These two components are mainly responsible for the color of the skin. They are measured by reflectance.

Change from baseline skin pH plusBaseline, 84 days

Skin pH will be measured using a Skin-pH-Meter.

Change from baseline skin hydrationBaseline, 84 days

Skin hydration will be measured using a Skin Corneometer.

Change in skin microbiomeBaseline, 84 days

For skin swabbing, a 3x3-cm square on a forearm will be swabbed with a cotton swab soaked in 0.9% sodium chloride with 0.1% Tween-20 in a Z-stroke manner.

Change in DNA damagesBaseline, 84 days

Urinary excretion of 8-oxo-2'-deoxyguanosine (8-oxo-dG) will be assessed using HPLC-MS/MS because it has been suggested as a sensitive marker for UV induced skin DNA damages.

Change in oxidative stressBaseline, 84 days

Malondialdehyde in plasma will be determined as a marker of lipid peroxidation using a photometric method.

Change in inflammationBaseline, 84 days

Plasma levels of C-reactive proteins will be analyzed as inflammation biomarkers using ELISA kits.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Food Science and Human Nutrition Department at University of Florida

🇺🇸

Gainesville, Florida, United States

© Copyright 2025. All Rights Reserved by MedPath